BioLife Corporate Profile

BioLife Corporate Profile

Financials

Current Annual Revenue
$15.2 billion

Current Gross Profit
$10.46 billion

Current Annual Net Income
$4.27 billion

2017 Fiscal Year
12.10%

 

Credit Rating

Moody's Rated: Baa3

BioLife Corporate Profile

BioLife Corporate Profile

Shire plc, a biotechnology company, focused on serving people with rare diseases and other specialized conditions worldwide. It has collaborative and other licensing arrangements with P zer Inc.; Precision BioSciences; Symphogen; Merrimack Pharmaceuticals, Inc.; Coherus Biosciences, Inc.; Momenta Pharmaceuticals, Inc.; SFJ Pharmaceuticals Group; and Rani erapeutics. Shire plc was founded in 1986 and is based in Dublin, Ireland.

ExchangeRight

1055 E. Colorado Blvd, Suite 310
Pasadena, CA 91106

Phone: (855) 317-4448
Fax: (877) 711-4047
Email: info@exchangeright.com

Subscribe

Receive our investment announcements and equity updates.